Bed Bath & Beyond Ausschüttungen und Rückkäufe
Zukünftiges Wachstum Kriterienprüfungen 1/6
Bed Bath & Beyond ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 2.61%.
Wichtige Informationen
2.6%
Dividendenausschüttung
-22.6%
Rückkaufsrendite
| Gesamte Aktionärsrendite | -22.6% |
| Zukünftige Dividendenrendite | 0% |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Ausschüttungsquote | n/a |
Jüngste Updates zu Dividenden und Rückkäufen
Keine Aktualisierungen
Recent updates
Narrativ-Update • Jun 23
BBBY: Everything Home Turnaround And Co Branded Expansion Will Shape Balanced Outlook
Analysts have lifted their Bed Bath & Beyond price target to $10 from $8, citing the company’s broader "Everything Home" platform approach, the potential for roughly $3 billion in annual revenue, and expectations for improving margins, cross-segment synergies, and multi-year operating leverage. Analyst Commentary Recent research on Bed Bath & Beyond frames the company as a turnaround story built around an "Everything Home" platform concept.
Narrativ-Update • Jun 06
BBBY: New Partnerships And Store Expansion Will Support Multiyear Turnaround
Analysts have lifted their Bed Bath & Beyond price target by $1 to $9.75, citing updated expectations for revenue growth, a revised fair value estimate, and a much higher assumed future P/E, even as projected profit margins are set at a lower level. What's in the News Shareholders approved an amendment to Bed Bath & Beyond's Certificate of Incorporation at the May 14, 2026 annual meeting, increasing authorized common stock from 100,000,000 to 200,000,000 shares, following an earlier proposal outlined ahead of the meeting.Narrativ-Update • May 23
BBBY: Core Initiatives And Co Branded Expansion Will Shape Balanced Outlook
Narrative Update on Bed Bath & Beyond The analyst price target for Bed Bath & Beyond has shifted to $6.00 from $7.00 as analysts balance a lower assumed fair value and a slightly adjusted discount rate against expectations for steadier revenue growth, modestly higher profit margins, and a lower future P/E multiple after recent mixed research updates. Analyst Commentary Recent research on Bed Bath & Beyond reflects a cautious tone, with price targets adjusted in both directions around the current analyst consensus.Seeking Alpha • May 21
Bed Bath & Beyond: The Current Pop Is Fundamentally Not Justified, The Reasons To Sell
Summary Despite increasing revenues and recent investor optimism Bed Bath & Beyond, Inc. (BBBY) remains fundamentally unattractive. BBBY's active customer base and order frequency are deteriorating, indicating ongoing demand challenges. While Marcus Lemonis has a strong track record of turning struggling businesses around, the recent agreement to acquire The Container Store brings in additional risks. Current market conditions and company fundamentals suggest caution regarding BBBY's investment outlook. Read the full article on Seeking AlphaNarrativ-Update • May 05
BBBY: Core Business Inflection And SKU Consolidation Will Support Future Repricing
Narrative Update Analysts have maintained their average $7.00 price target on Bed Bath & Beyond, with recent research citing mixed signals. Higher projected revenue growth and a very high future P/E multiple are being weighed against materially lower margin assumptions and ongoing execution uncertainty.Narrativ-Update • Apr 21
BBBY: Core Business Inflection And SKU Consolidation Will Drive Future Upside
Analysts have trimmed their average price targets for Bed Bath & Beyond to a range of about $7 to $8 from prior levels near $10 to $13, citing a mix of sequential improvement in the core business, cautious views on the execution of internal initiatives, and a valuation reset based on updated EBITDA assumptions. Analyst Commentary Recent research updates highlight that price targets for Bed Bath & Beyond have been pulled back into the high single digits, with analysts pointing to a mix of operational progress and ongoing execution risk.Narrativ-Update • Apr 07
BBBY: SKU Consolidation And Core Business Inflection Will Support Durable Turnaround
Analysts have trimmed Bed Bath & Beyond's average price target to a range anchored around $7 to $8. This reflects cautious views on execution risks even as they point to early signs of improvement in the core business, including SKU consolidation progress and steadier online trends.Narrativ-Update • Mar 23
BBBY: Website Momentum And SKU Consolidation Will Support Multiyear Turnaround
Analysts have trimmed their average price target for Bed Bath & Beyond by $0.40. They are tying the shift to mixed Q4 takeaways, where improving core trends and SKU consolidation are being weighed against lower margin expectations and ongoing uncertainty around the multiyear turnaround plan.Narrativ-Update • Mar 09
BBBY: Lemonis Leadership And SKU Consolidation Will Support Renewed Core Business Momentum
Analysts have trimmed their average price target on Bed Bath & Beyond to a range around $7 to $8, reflecting updated P/E assumptions and caution around execution, even as they point to improving website trends and early traction from internal initiatives such as SKU consolidation. Analyst Commentary Recent research updates show that bearish analysts are trimming price targets even as they acknowledge some operational progress in the core business and on initiatives like SKU consolidation.Narrativ-Update • Feb 23
BBBY: Website Momentum And 2027 EBITDA Outlook Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Bed Bath & Beyond from $10.90 to $9.80, tying the lower target to a reduced revenue outlook and higher assumed discount rate, partly balanced by expectations for slightly stronger profit margins and a higher future P/E multiple. Analyst Commentary Recent Street research highlights a mix of optimism and caution around Bed Bath & Beyond, with valuation expectations reset lower even as some early signs in the core business draw interest.Narrativ-Update • Feb 09
BBBY: Leadership Consolidation Under Lemonis Will Support A More Bullish Outlook
Analysts have adjusted their price target on Bed Bath & Beyond to US$7.00, reflecting small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall fair value view unchanged at US$7.00. What's in the News On December 30, 2025, Bed Bath & Beyond's Board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026.Narrativ-Update • Jan 25
BBBY: Higher US$8 Outlook And Buybacks Will Shape A Cautious Fairly Valued Path
Narrative Update: Bed Bath & Beyond Analyst Price Target Shift Analysts have lifted their 12 month price target on Bed Bath & Beyond to US$8 from US$5, citing refreshed post earnings models that reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary highlights that even with the price target increase to US$8, some research views remain cautious.Analyseartikel • Jan 23
Revenues Not Telling The Story For Bed Bath & Beyond, Inc. (NYSE:BBBY) After Shares Rise 31%
Those holding Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares would be relieved that the share price has rebounded 31% in...Narrativ-Update • Jan 11
BBBY: Earnings Refit And Buyback Activity Set A Cautious Path Forward
Analysts lifted their price target on Bed Bath & Beyond to US$8.00 from US$5.00, citing updated earnings assumptions that reflect changes to fair value, discount rate, revenue growth, profit margin and future P/E expectations. Analyst Commentary While the updated price target of US$8.00 reflects refreshed earnings assumptions, bearish analysts still frame the stock as a higher risk proposition rather than a clear upside story.Narrativ-Update • Dec 14
BBBY: Margin Gains And Buyback Support Brighter Outlook Ahead
Analysts have raised their price target on Bed Bath & Beyond to $8 from $5, citing updated post-earnings models that reflect slightly higher profit margin expectations despite more modest projected revenue growth and a higher assumed future valuation multiple. Analyst Commentary Bearish analysts acknowledged that the higher price target reflects improved margin visibility following the latest earnings update, but they emphasized that the new $8 objective still implies limited upside from current levels.Analyseartikel • Nov 02
Some Bed Bath & Beyond, Inc. (NYSE:BBBY) Shareholders Look For Exit As Shares Take 36% Pounding
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders won't be pleased to see that the share price has had a very rough...Analyseartikel • Oct 31
Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders are probably feeling a little disappointed, since its shares fell...Analyseartikel • Sep 09
Bed Bath & Beyond, Inc.'s (NYSE:BBBY) Shares Climb 31% But Its Business Is Yet to Catch Up
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares have continued their recent momentum with a 31% gain in the last month...Narrativ-Update • Aug 07
E-commerce And Luxury Retail Trends Will Unlock Value
The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples. What's in the News Beyond, Inc.Analyseartikel • Aug 05
Health Check: How Prudently Does Beyond (NYSE:BYON) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Jul 09
Revenues Not Telling The Story For Beyond, Inc. (NYSE:BYON) After Shares Rise 27%
Despite an already strong run, Beyond, Inc. ( NYSE:BYON ) shares have been powering on, with a gain of 27% in the last...Analyseartikel • May 13
What Beyond, Inc.'s (NYSE:BYON) 29% Share Price Gain Is Not Telling You
Beyond, Inc. ( NYSE:BYON ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last...Seeking Alpha • Apr 22
Beyond: Liberation Day Could Be A Disaster For Margins
Summary BYON faces severe financial distress with an 83% stock price drop, negative free cash flow, and liquidity issues set to be exacerbated by tariffs. The company's strategy of acquiring failed brands has not succeeded, leading to asset sales and further liquidity concerns amid recession fears. Fiscal 2024 fourth quarter revenue dropped 21.1% over its year-ago comp, missing estimates, with negative adjusted EBITDA and EPS. Liberation Day tariffs, especially a 145% tariff on Chinese imports, pose significant risks, making BYON a sell due to intense cash burn and uncertainty. Read the full article on Seeking Alpha
Neues Narrativ • Apr 01
Expense Cuts And Vendor Consolidation Will Streamline Operations
Vendor consolidation and SG&A reductions are poised to enhance profitability and strengthen margins by streamlining operations and costs.Seeking Alpha • Mar 18
Beyond Stock.: Iconic Brands Versus Downward Trending Financials
Summary Beyond, Inc. is in a transition phase, rebranding under Bed Bath & Beyond, and aims to streamline SKUs to improve profitability amid a competitive market. Despite improving net income, Beyond, Inc. reported a 10.6% decline in revenue for 2024, marking the fourth consecutive year of revenue drops. The stock appears cheap with low valuation multiples, but significant risks and ongoing cash flow challenges warrant a cautious "hold" rating. Aggressive cost-cutting and competitive pressures from giants like Amazon and Walmart, along with macroeconomic uncertainties, pose substantial risks to Beyond, Inc.'s turnaround efforts. Read the full article on Seeking AlphaAnalyseartikel • Mar 10
Some Beyond, Inc. (NYSE:BYON) Shareholders Look For Exit As Shares Take 30% Pounding
Beyond, Inc. ( NYSE:BYON ) shares have retraced a considerable 30% in the last month, reversing a fair amount of their...Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von BBBY in der Vergangenheit stabil war.
Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von BBBY gestiegen sind.
Dividendenrendite im Vergleich zum Markt
| Bed Bath & Beyond Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (BBBY) | 2.6% |
| Untere 25 % des Marktes (US) | 1.4% |
| Markt Top 25 % (US) | 4.2% |
| Branchendurchschnitt (Specialty Retail) | 2.1% |
| Analystenprognose (BBBY) (bis zu 3 Jahre) | 0% |
Bemerkenswerte Dividende: BBBYDie Dividende des Unternehmens (2.61%) ist höher als die der untersten 25% der Dividendenzahler auf dem US Markt (1.38%).
Hohe Dividende: BBBYDie Dividende des Unternehmens (2.61%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt US (4.2%) niedrig.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von BBBY, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da BBBY keine Ausschüttungen gemeldet hat.
Entdecken Sie dividendenstarke Unternehmen
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/24 07:21 |
| Aktienkurs zum Tagesende | 2026/06/24 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Bed Bath & Beyond, Inc. wird von 13 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Seth Sigman | Barclays |
| Daniel Kurnos | Benchmark Company |
| Curtis Nagle | BofA Global Research |